Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
Sylvie Bonvalot(Institut Curie), Rick L. Haas(Leiden University), Marco Fiore(Fondazione IRCCS Istituto Nazionale dei Tumori), Angelo Paolo Dei Tos(Ca' Foncello Hospital), Hans Gelderblom(Leiden University Medical Center), Jean‐Yves Blay(Centre Léon Bérard), Frits van Coevorden(The Netherlands Cancer Institute), Antonino De Paoli(Centro di Riferimento Oncologico), Chandrajit P. Raut(Brigham and Women's Hospital), Stephan Stoldt(Oslo University Hospital), D. Strauß(Royal Marsden Hospital), Sandrine Marréaud(European Organisation for Research and Treatment of Cancer), Charles Honoré(Institut Gustave Roussy), Aisha Miah(Institute of Cancer Research), Daphne Hompes, Claudia Sangalli(Fondazione IRCCS Istituto Nazionale dei Tumori), Alessandro Gronchi(University of Milan), Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), Pierre Méeus(Centre Léon Bérard), Marco Rastrelli(Istituti di Ricovero e Cura a Carattere Scientifico), Eberhard Stoeckle(Institut Bergonié), Jean‐Jacques Stelmes(European Organisation for Research and Treatment of Cancer), Saskia Litière(European Organisation for Research and Treatment of Cancer), Peter Chung(Princess Margaret Cancer Centre), C. Le Péchoux(Institut Gustave Roussy), Elizabeth H. Baldini(Dana-Farber Cancer Institute), Carol J. Swallow(Princess Margaret Cancer Centre)
Cited by 482
Related Papers
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k